Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
B. Oran*, K.W. Ahn, C. Fretham, A. Beitinjaneh, A. Bashey, A. Pawarode, B. Wirk, B.L. Scott, B.N. Savani, C. Bredeson, D. Weisdorf, D.I. Marks, D. Rizzieri, E. Copelan, G.C. Hildebrandt, G.A. Hale, H.S. Murthy, H.M. Lazarus, J. Cerny, J.L. LiesveldJ.A. Yared, J. Yves-Cahn, J. Szer, L.F. Verdonck, MahmoudAljurf MahmoudAljurf, M. van der Poel, M. Litzow, M. Kalaycio, M.R. Grunwald, M. AngelDiaz, M. Sabloff, M.A. Kharfan-Dabaja, N.S. Majhail, N. Farhadfar, R. Reshef, R.F. Olsson, R.P. Gale, R. Nakamura, S. Seo, S. Chhabra, S. Hashmi, S. Farhan, S. Ganguly, S. Nathan, TaigaNishihori TaigaNishihori, T. Jain, VaibhavAgrawal VaibhavAgrawal, U. Bacher, U. Popat, W. Saber
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes'. Together they form a unique fingerprint.